Cornell biomedical engineers have found natural triggers that can override developmental, biological miscues – research that could reduce the chance of congenital heart defects.
Combining genetic information from tumor cells with 3-D cell cultures grown from these tumors, and rapidly screening approved drugs, can identify the best treatment approaches in patients.
Dr. Juan R. Cubillos-Ruiz and Dr. Dan Landau have won Stand Up to Cancer (SU2C) grants totaling nearly $1.5 million for innovative research projects in ovarian cancer and combination cancer therapy.
One-year grants will help six institutions test promising obesity prevention interventions that could make healthy choices easier for low-income families.
Cornell researchers have developed an experimental strategy to identify infertility-causing mutations found in human populations, with implications for diagnoses and treatments.
Researchers at Weill Cornell Medical College have discovered that a known biomarker of bone mineral density also can be used to monitor the effects of testosterone therapy in men who suffer from osteoporosis.
A team of researchers has sequenced the genome of classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. The findings could pave the way to delivering personalized treatments.